Cargando…
Dkk1: A key molecule in joint remodelling and fibrosis
Dickkopf-1 (Dkk-1) is a Wnt signaling pathway inhibitor that has been shown to play an important role in joint remodeling, in experimental models of arthritis and in humans. Recent data suggest that this molecule is involved in the fibrotic process as well. OBJECTIVES: This review summarizes all the...
Autores principales: | Klavdianou, Kalliopi, Liossis, Stamatis-Nick, Daoussis, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7045998/ https://www.ncbi.nlm.nih.gov/pubmed/32185280 http://dx.doi.org/10.31138/mjr.28.4.174 |
Ejemplares similares
-
B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis
por: Daoussis, Dimitrios, et al.
Publicado: (2016) -
Treatment of systemic sclerosis associated fibrotic manifestations: Current options and future directions
por: Daoussis, Dimitrios, et al.
Publicado: (2019) -
B cells tell scleroderma fibroblasts to produce collagen
por: Daoussis, Dimitrios, et al.
Publicado: (2013) -
Molecular Mechanisms of New Bone Formation in Axial Spondyloarthritis
por: Klavdianou, Kalliopi, et al.
Publicado: (2022) -
B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence
por: Daoussis, Dimitrios, et al.
Publicado: (2011)